Among these, the euchromatic histone-lysine N-methyltransferase 2 (EHMT2) inhibitor UNC0642 displayed a cooperative effect with CFZ in a large panel of MM cell lines tested (including 4 PIR models). Here, EHMT2 is linked to Miyoshi myopathy.